Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Compounds And Methods Targeting Interleukin 34
Abstract: The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for treating immune-mediated diseases such as neurodegenerative diseases, for example Alzheimer's Disease or a tauopathy disease.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
24 May 2024
Publication Number
31/2024
Publication Type
INA
Invention Field
BIOTECHNOLOGY
Status
Email
Parent Application
Applicants
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, Indiana 46285
Inventors
1. CHEDID, Marcio
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
2. FLEISHER, Adam S.
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
3. LANNAN, Megan Brittany
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
4. LO, Albert
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
5. MINTUN, Mark
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
6. OBUNGU, Victor H.
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
7. RAINES, Sarah Elisabeth
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
8. SIMS, John Randall II
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
9. SKORA, Andrew Dixon
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
10. WALSH, Robin Elizabeth
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
11. WEST, Elizabeth Anne
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
12. YE, Ming
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202417040466-STATEMENT OF UNDERTAKING (FORM 3) [24-05-2024(online)].pdf | 2024-05-24 |
| 3 | 202417040466-Sequence Listing in PDF [24-05-2024(online)].pdf | 2024-05-24 |
| 4 | 202417040466-REQUEST FOR EXAMINATION (FORM-18) [24-05-2024(online)].pdf | 2024-05-24 |
| 5 | 202417040466-PRIORITY DOCUMENTS [24-05-2024(online)].pdf | 2024-05-24 |
| 6 | 202417040466-POWER OF AUTHORITY [24-05-2024(online)].pdf | 2024-05-24 |
| 7 | 202417040466-FORM 18 [24-05-2024(online)].pdf | 2024-05-24 |
| 8 | 202417040466-FORM 1 [24-05-2024(online)].pdf | 2024-05-24 |
| 9 | 202417040466-DRAWINGS [24-05-2024(online)].pdf | 2024-05-24 |
| 10 | 202417040466-DECLARATION OF INVENTORSHIP (FORM 5) [24-05-2024(online)].pdf | 2024-05-24 |
| 11 | 202417040466-COMPLETE SPECIFICATION [24-05-2024(online)].pdf | 2024-05-24 |
| 12 | 202417040466-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [24-05-2024(online)].pdf | 2024-05-24 |
| 13 | 202417040466-Proof of Right [19-06-2024(online)].pdf | 2024-06-19 |
| 14 | 202417040466-Others-240724.pdf | 2024-07-26 |
| 15 | 202417040466-Correspondence240724.pdf | 2024-07-26 |
| 16 | 202417040466-FORM 3 [14-10-2024(online)].pdf | 2024-10-14 |